Citation Impact
12 from Science/Nature 63 standout
Citing Papers
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Targeting the Warburg Effect in Cancer: Where Do We Stand?
2024 Standout
Works of Alex Renn being referenced
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells
2018
Author Peers
| Author | Molecular Biology | Neurology | Epidemiology | Infectious Diseases | Health Informatics | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Alex Renn | 32 | 9 | 11 | 62 | 57 | 8 | 173 | |
| Vanessa Infantini | 1 | 6 | 312 | |||||
| Marzena Malińska | 4 | 7 | 1 | 12 | 209 | |||
| Robert Goffee | 17 | 1.0k | ||||||
| Jimmy K. Guo | 229 | 1 | 3 | 3 | 9 | 243 |
All Works
Login with ORCID to disown or claim papers
Loading papers...